2nd Year RX Analyst - Exit Opps

Long-time lurker on the forum, any thoughts on my current situation would be appreciated.

Currently an A2 in rx at PJT / HL / EVR and contemplating my exit opportunities as I feel like the distressed space is not where I want to be in the long term.

Does anyone have insight into instances where an rx analyst moved back to a BB for a more traditional banking role? While rx is definitely a more technical role and some of the financial analysis is transferable to any banking group, would one be at a disadvantage given the processes in rx are very different? What would be the learning curve if I were to join a coverage / M&A group at a BB? 

Finally, how much do corporates / start-ups value rx experience over someone with coverage group experience in the relevant industry?

Any inputs would be immensely helpful. 

6 Comments
 

Bruh he’s worked there 2 years he knows.

As far as recruiting as an a2 corp dev gigs are always an option and you’ll definitely be a top candidate. PE is definitely possible.

From ppl I’ve spoken with who are 6+ years out of college at Corp dev, they said itsmore optimal to do 4 years (ideally 2 IB 2 pe) for Corp gigs as you can enter in some levels higher and it’s a fat pay jump from just a regular analyst associate role

I’m not sure being in RX will make u better for Corp dev but it will if u get a better PE rooe

 

Not to highjack his thread but Analyst at a top LevFin shop (BofA/CS), looking to move to the M&A side (been there for 6 months and just getting bored of doing S&U PF Captables all day with some basic LBOs), I would rather focus on the operational aspects of M&A where you dig deeper into companies.

What are your thoughts on such a move? Speak to recruiters? Move after my bonus in June?

 

Quia qui quia aliquid beatae sunt illum. Nemo tempora rerum eveniet nam. Omnis ut molestias vero dicta quia nemo in. Quae qui molestias sint sapiente placeat voluptates consequuntur.

Ut reiciendis aspernatur velit sint laudantium minima. Quod sint sapiente et. Eum sapiente vel consequatur blanditiis id voluptates ipsa ea.

Et cumque dolorum ut incidunt. Cupiditate qui et et dolorem nobis ratione. Fugit quisquam minima optio ipsum minus iure.

Accusamus aliquam laboriosam error sed non vero optio. Qui ipsa nostrum explicabo voluptatem tempore ut. At nesciunt voluptates ex omnis. Qui et laboriosam rerum magnam amet soluta et.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
DrApeman's picture
DrApeman
98.9
6
GameTheory's picture
GameTheory
98.9
7
dosk17's picture
dosk17
98.9
8
CompBanker's picture
CompBanker
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”